<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Serum metabolites (glycolysis pathway) is_biomarker_for Colorectal Cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Serum metabolites (glycolysis pathway)</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Colorectal Cancer</strong>
</div>
<div class="entity-id">UNKNOWN:serum metabolites (glycolysis pathway) &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 31.89<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 17 citations: <strong>31.89</strong><br><span style="color:#888">7&times; extends (+15.60) &middot; 8&times; supports (+4.29) &middot; 2&times; applies (+12.00)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1021/acs.analchem.6b00885">10.1021/acs.analchem.6b00885</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 17 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>8</span><span class="cite-subtotal">&middot; +4.29</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidic acid (PA 18:0/18:0) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b4e29af45fe71338.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidic acid (PA 18:0/18:0) — increases → pMMR colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5feb6356c8b8ee33.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phospholipids — decreases → dMMR colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1d597a9d341965ab.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SCD1 — increases → pMMR colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5dd384b0dd8d96c4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PLD1 — increases → pMMR colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/0b32621b68a46dd5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acetate — increases → colon cancer cachexia</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7f52378e159bcfc1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysine + acetate panel — distinguishes → colon cancer cachexia vs noncachexia cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/acf0861588e8970a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:88px"></span><span>7</span><span class="cite-subtotal">&middot; +15.60</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — increases → pMMR colorectal cancer cells</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5b3a7f36cd7281d1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SCD1 — is_biomarker_for → colorectal cancer metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/39b10d3311891ab5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PLD1 — is_biomarker_for → colorectal cancer metastasis</span><span class="cite-claim-weight">+0.60</span><a href="../claim/21d8dff9f78b4f00.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">diterpenoids — is_biomarker_for → cytotoxic activity against tumor cell lines</span><span class="cite-claim-weight">+12.00</span><a href="../claim/187668495ab44684.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysine — increases → colon cancer cachexia</span><span class="cite-claim-weight">+0.60</span><a href="../claim/3dde4a72a520854f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysine — is_biomarker_for → colon cancer cachexia</span><span class="cite-claim-weight">+0.60</span><a href="../claim/55b1e635631625a8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acetate — is_biomarker_for → colon cancer cachexia</span><span class="cite-claim-weight">+0.60</span><a href="../claim/53c8bf8088851bb5.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:25px"></span><span>2</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">13-keto-1,11-dolabell-3(E),7(E),12(18)-triene — distinguishes → cytotoxic vs non-cytotoxic soft coral extracts (A549)</span><span class="cite-claim-weight">+6.00</span><a href="../claim/f75d36eeb875872c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">13-keto-1,11-dolabell-3(E),7(E),12(18)-triene — distinguishes → cytotoxic vs non-cytotoxic soft coral extracts (SiHa)</span><span class="cite-claim-weight">+6.00</span><a href="../claim/0295b0c9d8a57027.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>41b412d0c8bbbc5b</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:serum metabolites (glycolysis pathway)">UNKNOWN:serum metabolites (glycolysis pathway)</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
